|
⚲
|
| Keyboard |
| Aerovate Therapeutics Inc | |
|---|---|
| Ticker | JBIO |
| CIK # | 0001798749 |
| CUSIP | 008064206 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 200 Berkeley Street Floor 18, Boston, MA 02116 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Aerovate Therapeutics Inc | 2020-08-14 | 75.8 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001798749] | 10-K | |
| [0001798749] | 10-Q | |
| [0001798749] | 3 | |
| [0001798749] | 4 | |
| [0001798749] | 8-K | |
| [0001798749] | D | |
| [0001798749] | SC 13D | |
| [0001798749] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Balta Elizabeth
Common Stock
|
2026-02-12 | Grant | 28,125 | $0.00 | |
|
Dahms Bradford D
Common Stock
|
2026-02-12 | Grant | 37,813 | $0.00 | |
|
King Andrew James
Stock Option (Right to Buy) · derivative
|
2026-02-12 | Grant | 247,500 | $0.00 | |
|
Dahms Bradford D
Stock Option (Right to Buy) · derivative
|
2026-02-12 | Grant | 226,875 | $0.00 | |
|
Balta Elizabeth
Stock Option (Right to Buy) · derivative
|
2026-02-12 | Grant | 168,750 | $0.00 | |
|
Frohlich Tom
Common Stock
|
2026-02-12 | Grant | 78,750 | $0.00 | |
|
Frohlich Tom
Stock Option (Right to Buy) · derivative
|
2026-02-12 | Grant | 472,500 | $0.00 | |
|
King Andrew James
Common Stock
|
2026-02-12 | Grant | 41,250 | $0.00 | |
|
Kiselak Tomas +4
Common Stock
|
2025-10-06 | Grant | 1,333,126 | $9.14 | 12,184,772 |
|
Kiselak Tomas +4
Pre-Funded Warrant (Right to Buy) · derivative
|
2025-10-06 | Grant | 855,047 | $9.14 | 7,815,130 |
|
Dahms Bradford D
Stock Option (Right to Buy) · derivative
|
2025-07-14 | Grant | 526,000 | $0.00 | |
|
Frohlich Tom
Common Stock
|
2025-05-16 | Buy | 6,000 | $7.40 | 44,400 |
|
Lavelle Erin
Stock Option (Right to Buy) · derivative
|
2025-04-29 | Grant | 23,017 | $0.00 | |
|
Klein Lawrence Otto
Stock Option (Right to Buy) · derivative
|
2025-04-29 | Grant | 23,017 | $0.00 | |
|
Cain Christopher W
Stock Option (Right to Buy) · derivative
|
2025-04-29 | Grant | 23,017 | $0.00 | |
|
Dobmeier Eric
Stock Option (Right to Buy) · derivative
|
2025-04-29 | Grant | 23,017 | $0.00 | |
|
Kiselak Tomas +3
Stock Option (Right to Buy) · derivative
|
2025-04-29 | Grant | 23,017 | $0.00 | |
|
Shah Rajeev M +3
Common Stock
|
2025-04-28 | Other | 1,062,326 | ||
|
Dake Benjamin T
Stock Option (Right to Buy) · derivative
|
2024-08-01 | Option exercise | 1,507 | $0.00 | |
|
Dake Benjamin T
Common Stock
|
2024-08-01 | Option exercise | 1,507 | $1.74 | 2,622 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 122 | 51,458,099 |
| 2025-12-31 | 107 | 47,170,869 |
| 2025-09-30 | 79 | 31,688,916 |
| 2025-06-30 | 74 | 31,593,490 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Gamma Investing LLC | [2026-06-30] | DFND | 916 | 916 |
| Versant Capital Management Inc | [2026-06-30] | SOLE | 905 | 905 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 66 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 29 | 29 |
| Ares Financial Consulting LLC | [2026-06-30] | SOLE | 20 | 20 |
| Owl Creek Wealth Partners LLC | [2026-06-30] | SOLE | 0 | 7 |
| Capital Advisors Ltd LLC | [2026-06-30] | SOLE | 0 | 6 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 6 | 6 |
| Hughes Financial Services LLC | [2026-06-30] | SOLE | 2 | 2 | Prev | Page 1 | Next |